Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Certolizumab pegol

Brand: Cimzia®
NICE TA: 
Indication: Crohn's disease
Disease category: Gastro-intestinal system
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Whilst there is evidence of efficacy in Crohns Disease from trials and retrospective observational studies of certolizumab, this evidence is insufficient to support their off-label use ahead of licensed and NICE-recommended agents, or following exhaustion of licensed and NICE-recommended agents.

Recommendation

LMMG recommendation: Black
Click here to find the definitions for the colour classifications

Reason for decision:  Not recommended for prescribing on the NHS in Lancashire

Supporting documents:

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Black

Black

Black

Black

Black

Black